Section 809 Panel Releases Volume 1 Report and Recommendations
Client Alert | 1 min read | 02.06.18
In the FY2016 NDAA, Congress created the “Section 809 Panel” to review and streamline DoD acquisition regulations to “improv[e] the efficiency and effectiveness of the defense acquisition process and maintain defense technology advantage.” On January 31, the Panel released its Volume 1 Report, which includes recommendations on a number of topics, such as commercial buying, contract compliance and audit, defense business systems, and services and small business contracting. (The Panel’s Volume 2 and 3 Reports will be released in June 2018 and January 2019, respectively.)
Many of the Panel’s recommendations are deep in the legislative and regulatory weeds, but could have far reaching effects—e.g., implementing a single definition of “subcontractor” to replace the 27 different definitions currently scattered throughout various statutes and regulations; bifurcating commercial items into commercial products and commercial services; etc. The full Volume 1 Report is worth a read for those interested in (and impacted by) DoD acquisition reform.
We will also be providing further analysis on our blog in the coming weeks.
Contacts
Insights
Client Alert | 10 min read | 04.22.26
The EU Industrial Accelerator Act Proposal’s Significance for the Automotive Industry
On March 4, 2026, the European Commission proposed the Industrial Accelerator Act (IAA), a draft regulation that aims to reverse the decline of the EU’s manufacturing sector while supporting the adoption of cleaner technologies. This client alert is the third in a three-part series dedicated to the IAA. In our first alert, we provided an overview of the draft regulation. In a second alert, we took a closer look at the new foreign direct investment (FDI) review framework that the IAA would establish for certain strategic sectors. In this third and final instalment of the series, we focus on the implications of the proposal for the automotive industry.
Client Alert | 3 min read | 04.21.26
Client Alert | 7 min read | 04.20.26
EU Pharma Package: The “Bolar” Exemption Compromise Proposal
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
